RUA. Repositorio Institucional de la Universidad de Alicante
Publication
Otros (Other)
The role of estrogen receptors on ion channel regulation, electrical activity and insulin secretion in the human pancreatic β-cell line EndoC-βH1
The estrogen response pathway consists of three different estrogen receptors: estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and the G-protein coupled estrogen receptor (GPER). Activation of these receptors by the naturally occurring hormone 17β-estradiol (E2) results in a plethora of actions in virtually every organ. Exogenous ligands, including endocrine disruptors such as bisphenol A (BPA), can disrupt these responses by interfering with estrogen receptor-initiated pathways. This contributes to the disruption of hormone actions. In pancreatic β-cells, ERα has been associated with cell survival, insulin biosynthesis, and the preservation of functional β-cell mass, whereas ERβ has been linked to ion-channel regulation, electrical excitability, and insulin secretion. In mouse β-cells, prolonged exposure to BPA or selective ERβ activation with diarylpropionitrile (DPN) reduces voltage-dependent K+ currents, while E2 does not reproduce this effect. However, it remained unclear whether this ERβ-associated electrical remodeling is conserved in human β-cells. Moreover, despite the established role of ERα in β-cell survival and insulin biosynthesis, its contribution to voltage-dependent ion-channel activity and action-potential firing in human β-cells had received little attention. This thesis therefore investigated whether the BPA-induced K+ current phenotype described in mouse β-cells is reproduced in the human EndoC-βH1 cell line and examined how selective activation of ERα and ERβ by propylpyrazoletriol (PPT) and DPN, respectively, affects ion channel activity, electrical excitability, insulin content and insulin secretion. Chronic exposure to a low, environmentally relevant dose of BPA (1 nM, 48 h) reduced the total macroscopic K+ current of EndoC-βH1 cells. The effect became detectable after 18 h, it was reproduced by the ERβ agonist DPN — but not by E2, PPT or the GPER agonist G-1 — and was abolished by the ERβ antagonist PHTPP, yet the ERα antagonist MPP was without effect. Pharmacological dissection showed that BPA reduced the delayed-rectifier Kᵥ component (compatible with Kᵥ2.1/Kᵥ2.2) while leaving the large-conductance BK current unchanged, indicating a slow, ERβ-dependent and likely transcriptional remodeling of the β-cell K+ conductance. This provides the first direct test in a human β-cell of a phenomenon previously described only in rodents. PPT increased macroscopic Ca2+ current density and caused a small depolarizing shift in apparent activation, without significantly modifying Na+ or K+ currents. DPN reduced peak Na+ current without changing activation or steady-state inactivation, and decreased total K+ current without significantly altering total Ca2+ current. Both PPT and DPN depolarized the resting membrane potential, increased firing frequency, broadened the action potential and reduced its amplitude. These electrical changes translated only modestly into secretory output: none of the ligands (E2, BPA, PPT, DPN) significantly altered insulin content or absolute secretion, but basal secretion normalized to content was significantly reduced by DPN and E2. Overall, ERα and ERβ ligands remodel excitability in a human β-cell model through distinct ion-channel mechanisms, while BPA engages an ERβ-associated pathway that reduces Kv-enriched current. These electrical effects do not necessarily translate into increased insulin output, highlighting the importance of ligand identity, receptor context and exposure duration when evaluating estrogenic actions in the human β-cell.